Back to Journals » Hepatic Medicine: Evidence and Research » Volume 3

Hepatic Medicine: Evidence and Research


Archive: Volume 3, 2011

Rifaximin in the treatment of hepatic encephalopathy

Iadevaia MD, Del Prete A, Cesaro C, Gaeta L, Zulli C, Loguercio C

Hepatic Medicine: Evidence and Research 2011, 3:109-117

Published Date: 22 December 2011

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program

Cervio G, Trentadue J, D´Agostino DE, Luque C, Giorgi MA, Armoni J, Debbag R

Hepatic Medicine: Evidence and Research 2011, 3:99-106

Published Date: 19 September 2011

Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH

Darwiche H, Oh S-H, Steiger-Luther NC, Williams JM, Pintilie DG, Shupe TD, Petersen BE

Hepatic Medicine: Evidence and Research 2011, 3:89-98

Published Date: 5 September 2011

Autonomic dysfunction in chronic liver disease

Frith J, Newton JL

Hepatic Medicine: Evidence and Research 2011, 3:81-87

Published Date: 23 August 2011

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Tomiyama Y, Yoshioka N, Yanai Y, Kawase T, Nishina S, Hara Y, Yoshida K, Korenaga K, Korenaga M, Hino K

Hepatic Medicine: Evidence and Research 2011, 3:45-52

Published Date: 26 April 2011

Erratum

Xiao N, Shi S, Zhuang H

Hepatic Medicine: Evidence and Research 2011, 3:19-20

Published Date: 18 March 2011

Pathogenesis and management of alcoholic liver cirrhosis: a review

Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao

Hepatic Medicine: Evidence and Research 2011, 3:1-11

Published Date: 24 December 2010